Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 2/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.34 |
| ▸ | PPOX | P50336 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.31 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23609480 | 0.93 | PDK2 (0.42) | PDK2AKR1A1AKR1B1HSD11B1PPOX | |
| SCHEMBL25878975 | 0.90 | PDK2 (0.33) | PDK2HSD11B1 | |
| SCHEMBL22797179 | 0.89 | PDK2 (0.49) | PDK2AKR1A1AKR1B1HSD11B1ALDH1A1 | |
| SCHEMBL24728354 | 0.89 | PDK2 (0.49) | PDK2AKR1A1AKR1B1HSD11B1ALDH1A1 | |
| SCHEMBL29733681 | 0.89 | PDK2 (0.45) | PDK2AKR1A1AKR1B1HSD11B1S100A4 | |
| SCHEMBL22780112 | 0.89 | PDK2 (0.45) | PDK2AKR1A1AKR1B1HSD11B1S100A4 | |
| SCHEMBL25582517 | 0.86 | BACE1 (0.38) | PDK2HSD11B1KDM1A | |
| SCHEMBL25962064 | 0.86 | PDK2 (0.39) | PDK2HSD11B1ALDH1A1CYP1A2HPGD | |
| SCHEMBL25582528 | 0.86 | BACE1 (0.38) | PDK2HSD11B1KDM1A | |
| SCHEMBL25879051 | 0.86 | PDK2 (0.39) | PDK2HSD11B1ALDH1A1CYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11655206-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-23 | — | — | US | disclosed |
| US-11655206-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655206-B2 | Nitrogen-containing compound, electronic element, and electronic device | MNS1, NOS1, NPM1 | PDK2 3769/4885AKR1A1 4561/4885AKR1B1 4570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.